Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03042715 · ClinicalTrials.gov registry record
Psychological Intervention for Caregivers of Patients Undergoing Hematopoietic Stem Cell Transplantation (HCT)
A clinical trial of Stem Cell Transplant Complications, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 6
- Enrollment target
- 1
- Study location
NCT03042715 is a study of Stem Cell Transplant Complications that has completed, run by Massachusetts General Hospital. The registered enrollment target is 6 participants, below the 185-participant average among 15 other Stem Cell Transplant Complications trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03042715, a study of Stem Cell Transplant Complications, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is evaluating a psychological intervention for caregivers of patients undergoing stem cell transplantation. Phase 1 will include a qualitative phase to refine the intervention to specifically target the needs of caregivers Phase 2 of the trial will transition to an interventional randomization clinical trial
Conditions Studied
Interventions
- BEHAVIORAL Qualitative Interviews
Study Locations (1)
Massachusetts
- Massachusetts general Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-03-06 |
| Est. Completion | 2017-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03042715
The ClinicalTrials.gov registry entry for NCT03042715 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 185-participant average among 15 other Stem Cell Transplant Complications trials with a reported enrollment target (97% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stem Cell Transplant Complications appearing as the primary indexed condition, and to 1 intervention - of which Qualitative Interviews is the first listed.
NCT03042715 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03042715 about?
NCT03042715 is a clinical study titled "Psychological Intervention for Caregivers of Patients Undergoing Hematopoietic Stem Cell Transplantation (HCT)". This research study is evaluating a psychological intervention for caregivers of patients undergoing stem cell transplantation. Phase 1 will include a qualitative phase to refine the intervention to specifically target the needs of caregivers Phase 2 of the trial will transition to an intervention...
What is the current status of trial NCT03042715?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2017-03-06. Estimated completion is 2017-08-01.
What conditions does trial NCT03042715 study?
This clinical trial studies the following conditions: Stem Cell Transplant Complications.
What interventions are being tested in trial NCT03042715?
The interventions under investigation include: Qualitative Interviews (BEHAVIORAL).
Who is sponsoring clinical trial NCT03042715?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03042715 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stem Cell Transplant Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors
RECRUITING · NA
-
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
RECRUITING · Phase 2
-
Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
RECRUITING · NA
-
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
RECRUITING · Phase 3
-
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
RECRUITING
-
IS-free Treg HaploHCT
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.